Physician profile
Christopher Charles Thacker
NPI 1881658664
$2,827.53
in general payments reported to CMS, 2019-2025
26 companies · $653 in 2025
The $653 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $41.62 · 2021: $76.11 · 2022: $232 · 2023: $333 · 2024: $1,347 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320 · Travel and Lodging: $972 · Education: $40.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.14 |
| Travel and Lodging | $971.94 |
| Education | $40.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,080.58 | 2024-2025 | Aquabeam System |
| Janssen Biotech, INC. | $272.26 | 2023-2025 | Erleada |
| Sumitomo Pharma America, INC. | $195.35 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $192.26 | 2021-2024 | Urolift |
| Dendreon Pharmaceuticals LLC | $160.58 | 2019-2024 | Provenge |
| Boston Scientific Corporation | $130.60 | 2019-2024 | Tria Firm |
| Tolmar, INC. | $100.53 | 2023 | |
| Urogen Pharma, INC. | $99.20 | 2023-2025 | Jelmyto |
| Laborie Medical Technologies Corp. | $81.83 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $81.48 | 2019-2023 | Myrbetriq |
| Photocure INC | $53.87 | 2023-2025 | Cysview |
| Coloplast Corp | $47.65 | 2024 | |
| Rochester Medical Corporation | $44.11 | 2022 | |
| Accord Healthcare, INC. | $39.32 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $28.97 | 2024 | |
| Ferring Pharmaceuticals INC. | $25.84 | 2025 | Adstiladrin |
| Dentsply Ih Ab | $25.73 | 2025 | Lofric |
| Pfizer INC. | $23.01 | 2024 | |
| Medtronic, INC. | $22.88 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $20.88 | 2025 | |
| Myriad Genetic Laboratories, INC. | $20.28 | 2024 | Prolaris |
| Olympus America INC. | $14.99 | 2025 | Itind System |
| Neotract INC. | $12.72 | 2020 | |
| Medtronic USA, INC. | $11.99 | 2019 | |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.